Can memantine be administered via a gastrostomy tube (G-tube)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can Memantine Be Given Via G-Tube?

Yes, memantine can be administered via gastrostomy tube (G-tube), though the FDA label does not specifically address enteral tube administration, requiring consultation with a pharmacist for proper preparation and technique.

Key Considerations for Administration

Formulation Requirements

The FDA label for memantine does not explicitly discuss G-tube administration 1. However, drugs may be administered individually through an enteral feeding tube when the tube is flushed before, between, and after each drug using 30 mL of water 2. This general principle applies to memantine when appropriate formulation is used.

Critical Safety Steps

Before administering memantine via G-tube, you must:

  • Confirm the necessity and appropriateness of G-tube administration, considering the site of drug delivery and potential interactions with enteral formula 2
  • Involve a pharmacist to advise on proper preparation, as they are ideally positioned to recommend alternative formulations or management options 2
  • Use appropriate ENFit syringes with recognized standard connectors to avoid misconnection errors 2

Administration Protocol

When giving memantine through a G-tube:

  1. Flush the tube with 30 mL water before administration 2
  2. Administer memantine individually (never mix with other medications) 2
  3. Flush with 30 mL water after administration 2
  4. Hold enteral feeding if memantine binds to formula (pharmacist consultation needed)

Important Caveats

Crushing tablets should be avoided whenever possible due to risks of drug exposure and dosing inaccuracies 2. If memantine tablets must be crushed for G-tube administration, this represents off-label use, and the prescriber assumes additional responsibility 2.

The site of the tube tip matters for drug efficacy - gastric delivery may differ from post-pyloric delivery 2. Since memantine is highly absorbed orally with food having no effect on absorption 1, gastric administration via G-tube should maintain therapeutic efficacy.

Pharmacokinetic Considerations

Memantine's favorable pharmacokinetic profile supports G-tube administration:

  • Highly absorbed orally with peak concentrations at 3-7 hours 1
  • Food does not affect absorption 1
  • Linear pharmacokinetics over therapeutic range 1
  • Minimal hepatic metabolism via CYP450 1

Monitoring Requirements

Watch for gastrointestinal side effects, as memantine can cause gastric dysmotility. Research in pigs showed memantine significantly increased gastric arrhythmia and altered myoelectric activity, particularly with repeated dosing 3. This may explain GI side effects (vomiting, diarrhea, constipation) seen clinically.

Ensure proper tube patency - use adequate flushing volumes (at least 30 mL) to prevent occlusion, especially with small-diameter tubes 2.

Urine pH Interaction

Be cautious with conditions that alkalinize urine (pH >8), as memantine clearance can be reduced by 80% under alkaline conditions, potentially increasing adverse effects 1. This includes patients on carbonic anhydrase inhibitors or sodium bicarbonate.

References

Related Questions

How can agitation be reduced in a patient with dementia who is taking sertraline 100 mg daily, memantine, donepezil, buspirone, and lorazepam (Ativan)?
Should memantine be continued on the day of a colonoscopy?
What is the optimal management for a 72‑year‑old patient with dementia who is refusing hygiene and medication, becoming agitated and aggressive toward staff, has low motivation and frequent incontinence, and is currently on donepezil 10 mg daily, memantine 10 mg daily, sertraline 150 mg daily, mirtazapine 15 mg daily (dose recently increased), olanzapine 2.5 mg daily, after discontinuation of valproic acid (Depakote) 125 mg twice daily one month ago?
Does gastroenterology manage a blocked gastrostomy tube (G-tube)?
What are the different types of gastrostomy and feeding jejunostomy tubes and their respective indications?
Should a 70-year-old HIV-negative gay male with normal renal function have his daily oral pre-exposure prophylaxis (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) prescription renewed?
What are the classic high‑yield pulmonology triads and their associated buzzwords?
How can electrolytes be assessed in a patient at home without hospital access?
How does digoxin affect heart rate, and what are the appropriate dosing and monitoring recommendations?
How does the bead-counting method work for tapering venlafaxine (extended-release) in a patient who has been taking 37.5 mg daily for over 20 years?
What cosmetic surgical options are available for Heberden nodes on the hands?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.